Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Is This NZ Retirement Stock Facing a Bigger Market Test?

This article takes a measured, factual look at why Summerset Group shares slipped during the latest NZX session, how that move fits into the broader market pullback, and what long-term investors may be weighing as they assess the retirement village and aged-care property operator. …

Anjali Anand | 24 June 2026

Is This Small-Cap Healthcare Stock Worth Watching?

Marginal daily declines often say more about market sentiment than about a company's fundamentals. On a day when the NZX experienced a broad market pullback, even fundamentally sound names can drift lower as investors trim exposure, rebalance portfolios, or simply react to softer global …

Anjali Anand | 24 June 2026

Why This NZ Healthcare Stock Is Back on Investor Radar

AFT is not a household name like the large multinational drugmakers, yet it occupies a distinctive niche, developing and distributing prescription pharmaceuticals and consumer-health products anchored by its widely recognised Maxigesic pain-relief range. For investors scanning the NZX for stock gainers with a credible …

Anjali Anand | 24 June 2026

Why EBOS Group Healthcare Distributor Remains on Watchlists

In a period when many New Zealand stocks have experienced choppy trading and uneven market momentum, EBO has quietly held the attention of those who prize scale, diversification and dependable cash generation. The company is one of Australasia's largest diversified healthcare businesses, and its …

Anjali Anand | 24 June 2026

Fisher & Paykel Healthcare Climbs: Is This NZ Healthcare Leader Back in Focus?

This article takes a balanced, qualitative look at why FPH is attracting attention, what underpins its business, and the opportunities and risks that investors may weigh. It does not attempt to forecast precise price levels or offer recommendations. Instead, it provides context on a …

Anjali Anand | 24 June 2026

Fisher & Paykel Healthcare (FPH) Slips: Is This NZ Healthcare Giant Just Taking a Breather?

A decline of 0.05% is about as small as a daily move can be, and for a company of FPH's quality and scale, it reflects little more than the gentle drift that can accompany a softer day across the New Zealand share market. Yet …

Anjali Anand | 24 June 2026

Promisia (NZX:PHL) Suprises Market with FY26 EBITDAF Target

Promisia Healthcare Limited (NZX:PHL) has upgraded its FY26 earnings guidance, increasing its forecast for underlying EBITDAF for the year ending 31 March 2026. The company now expects earnings before interest, tax, depreciation, amortisation and fair value adjustments to range betweenNZD 6.4 million and NZD …

Sonal Goyal | 13 February 2026

Ryman Healthcare (NZX:RYM) Unveils Refreshed Strategy and FY29 Targets

Ryman Healthcare Ltd (NZX:RYM)on Tuesday released its refreshed strategy, new capital management framework, and updateddividendpolicy at its Investor Day for investors and analysts. The announcement outlines the company’s priorities across cash flow generation, portfolio optimisation, and disciplined future growth, while maintaining existing FY26 guidance. …

Team Kalkine | 03 February 2026

Pacific Edge (NZX:PEB) Hits the Headlines. Here’s What Investors Need to Know.

Cancer diagnostics company, Pacific Edge Limited (NZX:PEB) has released its investor update for the three months ended December 2025 (Q3 FY26), outlining progress across Medicare engagement, clinical evidence development, laboratory testing volumes, and governance. The update centres on activities supporting potential reinstatement of US …

Team Kalkine | 20 January 2026